↓ Skip to main content

Participation of Gαi-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways

Overview of attention for article published in Frontiers in Pharmacology, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Participation of Gαi-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways
Published in
Frontiers in Pharmacology, February 2019
DOI 10.3389/fphar.2019.00146
Pubmed ID
Authors

Valeria Burghi, Emiliana B. Echeverría, Máximo H. Sosa, Diego T. Quiroga, Marina C. Muñoz, Carlos Davio, Federico Monczor, Natalia C. Fernández, Fernando P. Dominici

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 21%
Student > Doctoral Student 5 17%
Student > Ph. D. Student 3 10%
Researcher 3 10%
Professor 1 3%
Other 1 3%
Unknown 10 34%
Readers by discipline Count As %
Engineering 4 14%
Biochemistry, Genetics and Molecular Biology 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Agricultural and Biological Sciences 2 7%
Medicine and Dentistry 2 7%
Other 5 17%
Unknown 11 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 March 2019.
All research outputs
#15,035,034
of 23,132,033 outputs
Outputs from Frontiers in Pharmacology
#5,359
of 16,510 outputs
Outputs of similar age
#209,646
of 352,994 outputs
Outputs of similar age from Frontiers in Pharmacology
#207
of 356 outputs
Altmetric has tracked 23,132,033 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,510 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,994 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 356 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.